Risk of overseas production stoppages and rising production costs for private-label products
First written in FY2017. 14 of 28 entries say "Restated". Latest entry: FY2027-H1.
Asahi moved to the "Worse" side of this theme in 2021, 2 years before the typical company in this theme (2023).
The whole theme swung hardest in 2020: 4 of 20 companies on the "Worse" side.
20 other companies' latest entry also says "Restated".
- FY2027-H1RestatedAnnual report
「During the current interim accounting period, there were no new occurrences of the major risks that management recognizes as potentially having a material impact on the company's financial position, operating results or cash flows, among the matters relating to the business and accounting conditions described in the interim report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes regarding the risk of suspending overseas production of private-label products or rising production costs. - FY2025WorsenedAnnual report
「Purchases of these contract-manufactured products during the fiscal year amounted to ¥18,834.896 million, representing 42.9% of total purchases, with most production taking place in China.」
The proportion of purchases of contract-manufactured products, produced mainly in China, rose from 42.2% in the previous fiscal year to 42.9%, increasing exposure to the risks of production stoppages and higher production costs. - FY2025-H1RestatedAnnual report
「During the current interim accounting period, there were no new occurrences of the major risks that management recognizes as potentially having a material impact on the company's financial position, operating results or cash flows, among the matters relating to the business and accounting conditions described in the interim report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no new developments or material changes regarding the risk of suspending overseas production of private-label products or rising production costs. - FY2024WorsenedAnnual report
「Purchases of the contract-manufactured products during the fiscal year totaled ¥16,203,533 thousand, accounting for 42.2% of total purchases, and most were manufactured in China.」
The ratio of total purchases of contract-manufactured products sourced primarily from China rose from 41.1% in the previous fiscal year to 42.2%, increasing exposure to the risks of production stoppages and higher production costs. - FY2024-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no new business risks and no material changes in the business risks described in the annual securities report for the preceding fiscal year.」
The Company stated that there had been no new developments or material changes regarding the risk of overseas production stoppages and higher production costs for private-label products. - FY2023WorsenedAnnual report
「Purchases of the contract-manufactured products during the fiscal year totaled ¥17,118,725 thousand, accounting for 41.1% of total purchases, and most were manufactured in China. Consequently, future political and social conditions and the economic environment in the region could affect the company’s financial condition and operating results by disrupting production or increasing production costs.」
The ratio of purchases from contract manufacturers concentrated in China rose from 37.5% in the previous fiscal year to 41.1% of total purchases, increasing exposure to production stoppages and cost increases. - FY2023-Q3MaterialisedAnnual report
「In the bicycle industry, purchase prices rose substantially due to higher resource and ocean freight costs and the rapid weakening of the yen. Manufacturers raised selling prices, while supply chain disruptions caused by lockdowns in China extended lead times, resulting in unstable conditions.」
Higher procurement prices due to rising resource costs and ocean freight rates, as well as supply chain disruptions and longer lead times caused by China's lockdowns, actually occurred. - FY2023-Q1MaterialisedAnnual report
「In the bicycle industry, supply and demand changed after demand had expanded during the COVID-19 pandemic through the previous fiscal year. The factors are considered to include logistics disruptions caused by lockdowns in China, which resulted in double-digit year-on-year declines in import volumes for almost all types of bicycles, including standard and children's bicycles, as well as higher bicycle procurement prices resulting from surging resource costs and ocean freight rates, prompting manufacturers to raise selling prices.」
The company explains that logistics disruptions caused by lockdowns in China, double-digit declines in import volumes for almost all types of bicycles, and higher procurement prices due to surging resource costs and ocean freight rates actually occurred. - FY2022SoftenedAnnual report
「Purchases of products manufactured under contract during the fiscal year amounted to ¥14,211,979 thousand, accounting for 37.5% of total purchases, and most were manufactured in China. Consequently, future political and social conditions and the economic environment in China could affect the Company’s financial position and operating results through production disruptions, higher production costs and other factors.」
The risk of production stoppages and cost increases centered in China remains, but the ratio of outsourced-manufactured products to total purchases declined from 41.0% in the previous fiscal year to 37.5%. - FY2022-Q3RestatedAnnual report
「Meanwhile, in the sports cycle sector, supply and demand became tight as parts manufacturers faced supply shortages and production stoppages amid a worldwide increase in demand.」
Parts manufacturers continue to face supply shortages and production stoppages in response to the global increase in demand, while securing popular products remains difficult. Supply risks have continued to materialize since the previous quarter. - FY2022-Q2MaterialisedAnnual report
「Meanwhile, in the sports-cycle field, supply and demand tightened as increased global demand coincided with shortages of supply from component manufacturers and production stoppages. In sports cycles, the emergence of supply shortages made it difficult to secure popular products.」
The company states that supply shortages and production stoppages at parts manufacturers, as well as difficulty securing popular products, actually occurred against a backdrop of rising global demand. - FY2022-Q1WorsenedAnnual report
「These conditions arose not only in Japan but also in countries around the world, including the United States and Europe, while manufacturers continued to face unstable supply conditions, with production slowing because of parts shortages and other factors.」
The company states that production stoppages by manufacturers due to component shortages and unstable supply have continued worldwide, with the regions and factors subject to production and supply interruption risk expanding. - FY2021SoftenedAnnual report
「Purchases of the relevant contract-manufactured products during the fiscal year amounted to ¥14,568.696 million, representing 41.0% of total purchases, and most of these products are manufactured in China. Accordingly, depending on future political and social conditions and the economic environment in the region, production could be disrupted or production costs could rise, potentially affecting the company's financial condition and operating results.」
Although the risks of production stoppages and higher costs for private-label products produced mainly in China continue, the proportion of purchases of contract-manufactured products fell from 43.5% in the previous fiscal year to 41.0%. - FY2021-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no newly arising business or other risks. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2021-Q1RestatedAnnual report
「No new business or other risks arose during the cumulative first-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2020WorsenedAnnual report
「Purchases of products manufactured under contract amounted to ¥13,231 million during the fiscal year, accounting for 43.5% of total purchases, and most of these products are manufactured in China. Consequently, political and social developments and economic conditions in the region could disrupt production or increase production costs, potentially affecting the company's financial position and operating results.」
The ratio of PB products manufactured under production outsourcing arrangements to total purchases increased from 42.1% in the previous fiscal year to 43.5%, increasing exposure to the risk of production stoppages and cost increases centered in China. - FY2020-Q3RestatedAnnual report
「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2019SoftenedAnnual report
「Purchases of the contract-manufactured products during the current fiscal year totaled ¥11,978.020 million, accounting for 42.1% of total purchases, and most were manufactured in China. Accordingly, future political and social conditions and the economic environment in the region could disrupt production or increase production costs, affecting the company’s financial position and operating results.」
The ratio of products manufactured under PB production outsourcing arrangements to total purchases declined from 44.8% in the previous fiscal year to 42.1%. The risk of production stoppages and cost increases centered in China remains unchanged. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the current fiscal year, there were no occurrences of matters concerning the business situation, accounting situation or other matters described in the quarterly report that could have a material impact on investors’ decisions, and no material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2019-Q2RestatedAnnual report
「No new business or other risks arose during the cumulative second-quarter period. There were also no significant changes to the business and other risks described in the annual securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2019-Q1MitigatedAnnual report
「Although gross profit was expected to decline due to lower margins resulting from higher personnel and raw material costs, it exceeded the previous year as negotiations with production partners minimized cost increases and price revisions became fully reflected in sales.」
The Company explains that it minimized cost increases through negotiations with production partners and that revisions to selling prices have taken effect. This indicates measures to address the impact of rising production costs, rather than a change in the disclosure concerning the risk of production stoppages. - FY2018SoftenedAnnual report
「Purchases of the products manufactured under contract totaled ¥13,039 million for the current fiscal year, accounting for 44.8% of total purchases, with most production taking place in China. Accordingly, future political and social conditions and the economic environment there could disrupt production or increase production costs, potentially affecting the company's financial condition and business performance.」
The risk itself continues, but the ratio of outsourced production to total purchases declined from 49.3% in the previous fiscal year to 44.8%. - FY2018-Q3RestatedAnnual report
「During the cumulative third-quarter period, there were no newly arising business or other risks. There were also no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company stated that there had been no new developments or material changes regarding the risk of overseas production stoppages and higher production costs for private-label products. - FY2018-Q2RestatedAnnual report
「There were no newly arising business or other risks during the cumulative second quarter. There were also no material changes to the business or other risks described in the securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2018-Q1RestatedAnnual report
「No new business or other risks arose during the cumulative first quarter. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」
It is stated that there have been no material changes regarding the risk of suspending overseas production of private-label products and rising production costs. - FY2017First statedAnnual report
「Purchases of the relevant contract-manufactured products during the fiscal year amounted to ¥12,815.633 million, representing 49.3% of total purchases, and most of these products are manufactured in China. Accordingly, depending on future political and social conditions and the economic environment in the region, production could be disrupted or production costs could rise, potentially affecting the company's financial condition and operating results.」
The Company identifies the risks of production stoppages and higher costs, against the backdrop of private-label products manufactured under contract accounting for 49.3% of purchases and most of them being produced in China.